Conference Coverage
Conference Coverage
Myocardial infarction in women younger than 50: Lessons to learn
“Cardiovascular disease is the main cause of death in women, killing seven times more than breast cancer,” notes Dr. Manzo-Silberman.
Conference Coverage
Dietary change tops for reducing CVD risk in stage 1 hypertension
Healthy lifestyle changes, particularly adoption of the DASH diet, can reduce CVD events in people with stage 1 hypertension.
Conference Coverage
Full-dose antithrombotic aids selected COVID-19 ICU patients
“We probably need to replace the guidelines.”
Conference Coverage
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension study
The trial speaks to the lofty high-risk status of patients with CAD. ‘You’re seeing in a group of patients, with largely preserved EF but advanced...
Conference Coverage
Patisiran benefits ATTR amyloidosis with cardiomyopathy: APOLLO-B
More details of the positive results with the RNAi therapeutic on functional capacity and quality of life were reported.
Latest News
Candy, desserts: A ‘gateway’ to unhealthy eating among teens
Over the past 30 years, there’s been a steady increase in consumption of ultra-processed foods worldwide, coupled with mounting evidence that...
Conference Coverage
MR and PET perform similarly for assessing CAD
Head-to-head comparison of rubidium PET and cardiac MR showed comparable performance for identifying coronary obstructions.
Conference Coverage
AI-assisted reading of echocardiograms readily detects severe aortic stenosis
Moderate and severe aortic stenosis is identified accurately on echocardiograms by artificial intelligence.
Conference Coverage
New ESC cardio-oncology guideline aims to reduce cardiotoxicity
A “very strong theme throughout the guideline is risk assessment, and the fact that that risk is dynamic.”
Conference Coverage
Majority of muscle symptoms with statins not caused by treatment
A new Cholesterol Trialists Collaboration meta-analysis shows that in 14 of the 15 people who experience muscle pain or weakness when taking a...
Conference Coverage
Evolocumab benefits accrue with longer follow-up: FOURIER OLE
Chief among the benefits was a reduction in cardiovascular mortality not observed in the pivotal trial that led to U.S. approval of evolocumab.